0001209191-22-053212.txt : 20221011
0001209191-22-053212.hdr.sgml : 20221011
20221011090017
ACCESSION NUMBER: 0001209191-22-053212
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221007
FILED AS OF DATE: 20221011
DATE AS OF CHANGE: 20221011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brumm Joshua T
CENTRAL INDEX KEY: 0001528826
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 221302528
MAIL ADDRESS:
STREET 1: ZELTIQ AESTHETICS INC.
STREET 2: 4698 WILLOW ROAD SUITE 100
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-07
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001528826
Brumm Joshua T
C/O DYNE THERAPEUTICS, INC.
1560 TRAPELO ROAD
WALTHAM
MA
02451
1
1
0
0
See Remarks
Common Stock
2022-10-07
4
M
0
14200
1.03
A
218823
D
Common Stock
2022-10-07
4
S
0
14200
13.37
D
204623
D
Common Stock
2022-10-10
4
M
0
195800
1.03
A
400423
D
Common Stock
2022-10-10
4
S
0
195800
12.46
D
204623
D
Common Stock
2022-10-10
5
G
0
E
13000
0.00
D
191623
D
Common Stock
2022-10-10
5
G
0
E
2500
0.00
D
189123
D
Stock Option (right to buy)
1.03
2022-10-07
4
M
0
14200
0.00
D
2030-01-05
Common Stock
14200
543549
D
Stock Option (right to buy)
1.03
2022-10-10
4
M
0
195800
0.00
D
2030-01-05
Common Stock
195800
347749
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $12.70 to $13.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $12.30 to $12.91, inclusive.
This transaction was a charitable donation to a third party effective October 10, 2022 in which no value was received in return.
The option was granted on January 6, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on October 12, 2020 and the remaining shares vesting in equal quarterly installments thereafter.
Chief Executive Officer and President
/s/ Richard Scalzo, Attorney-in-Fact
2022-10-11